Clinical Trials Browser

Completed × Neoplasm Metastasis × Cetuximab × Clear all

NCT03082534 2026-01-28

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

NCT05271604 2025-09-26

A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00593060 2023-05-24

Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01001377 2022-09-21

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Phase 3 Completed

1,010 enrolled 22 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01864772 2022-08-19

ELANFIT

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT01442649 2022-01-11

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02095054 2021-04-01

Regorafenib and Cetuximab in Patients With Advanced Malignancy

Phase 1 Completed

Neoplasm Metastasis

NCT03031444 2021-02-01

PARECEC

Phase 2/3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02124707 2020-08-12

Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN

Phase 2 Completed

14 enrolled 17 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT00444678 2020-04-03

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Phase 2 Completed

36 enrolled 11 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02124148 2020-04-01

A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis

NCT02278133 2017-10-09

Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations

Phase 1/2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00350025 2017-03-31

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Phase 2 Completed

41 enrolled 11 charts

Neoplasm Metastasis, Neoplasms, Urologic Neoplasms

NCT00056030 2017-01-24

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00207116 2015-10-28

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT01030042 2015-07-15

COMETS

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00130689 2015-05-14

Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer

Phase 2 Completed

43 enrolled 6 charts

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT01082315 2014-08-29

A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00125034 2014-08-07

OPUS

Phase 2 Completed

344 enrolled 21 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00439517 2014-06-27

FUTURE

Phase 2 Completed

302 enrolled 18 charts

Neoplasm Metastasis, Neoplasms

NCT00705016 2014-04-30

ADVANTAGE

Phase 1/2 Completed

184 enrolled 20 charts

Neoplasm Metastasis, Recurrence, Neoplasms, Squamous Cell

NCT00463788 2014-02-13

BALI-1

Phase 2 Completed

181 enrolled 15 charts

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00557102 2012-12-11

ERBIFORT

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00083720 2011-05-25

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Phase 2 Completed

87 enrolled 14 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00544349 2011-05-17

Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00044863 2011-02-23

Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00536614 2007-09-28

SPaCe-01

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms